Showing results (151-160 of 181) with videos related to
Sort By:
Pageof 19
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 13, 2021
Implementation of a Rapid Phenotypic Susceptibility Platform for Gram-Negative Bloodstream Infections With Paired Antimicrobial Stewardship Intervention: Is the Juice Worth the Squeeze?Evan D Robinson, Allison M Stilwell, April E Attai, et al.Antimicrobial Agents and Chemotherapy|January 7, 2015
Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae at a single institution: insights into endemicity from whole-genome sequencingAmy J Mathers, Nicole Stoesser, Anna E Sheppard, et al.The Journal of Antimicrobial Chemotherapy|January 22, 2020
Genomic dynamics of species and mobile genetic elements in a prolonged blaIMP-4-associated carbapenemase outbreak in an Australian hospitalA Kizny Gordon, H T T Phan, S I Lipworth, et al.Antimicrobial Agents and Chemotherapy|December 30, 2016
Chromosomal Integration of the Klebsiella pneumoniae Carbapenemase Gene, blaKPC, in Klebsiella Species Is Elusive but Not RareAmy J Mathers, Nicole Stoesser, Weidong Chai, et al.Applied and Environmental Microbiology|April 16, 2021
Development of Wastewater Pooled Surveillance of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) from Congregate Living SettingsLisa M Colosi, Katie E Barry, Shireen M Kotay, et al.The Lancet. Infectious Diseases|January 20, 2025
A framework towards implementation of sequencing for antimicrobial-resistant and other health-care-associated pathogensAlison Laufer Halpin, Amy J Mathers, Timothy R Walsh, et al.Medrxiv : the Preprint Server for Health Sciences|April 12, 2022
Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients with Moderate to Severe COVID 19: A Phase IIa TrialJennifer Sasson, Alexandra N Donlan, Jennie Z Ma, et al.Open Forum Infectious Diseases|August 12, 2022
Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019: A Phase 2a TrialJennifer Sasson, Alexandra N Donlan, Jennie Z Ma, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 2, 2026
Global Survey on the Management of Multidrug-resistant Gram-negative Bacilli: Divergence of Practice Between High-Income Countries and the Rest of the WorldAbi Manesh, Abdullah T Aslan, Mithun Mohan George, et al.Journal of Clinical Microbiology|January 31, 2023
Evaluation of Piperacillin-Tazobactam Testing against Enterobacterales by the Phoenix, MicroScan, and Vitek2 Tests Using Updated Clinical and Laboratory Standards Institute BreakpointsCarmila Manuel, Richard Maynard, April Abbott, et al.Pageof 19